Clinical Trials
10 trialsNCT07428954 2026-02-24
LegitHealthSAN
AI Labs Group S.L
Completed
NCT07256015 2025-12-01
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Bristol-Myers Squibb
Recruiting
NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT05796245 2025-06-04
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer
Completed
NCT06989216 2025-05-25
DermaFlow
HJN Sverige AB/Neko Health
Recruiting
NCT06952465 2025-05-01
A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
Bristol-Myers Squibb
Active not recruiting
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT05635266 2024-05-07
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT01126619 2012-10-25
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis
Abbott
Completed